Evidence map›Paper›PMID 25561818›Full record

SynthesisWorld journal of gastroenterology2014

Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.

Jennifer Shroff, Nirav Thosani, Sachin Batra, Harminder Singh, Sushovan Guha

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Study ofJournal of gastrointestinal oncology · 2018
    Article
  16. [Multiple risk factors prediction models for high risk population of colorectal cancer].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2018
    Article
  17. Article
  18. Diagnostic Value of MethylatedFrontiers in oncology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jennifer ShroffJennifer Shroff, Nirav Thosani, Sachin Batra, Sushovan Guha, Division of Gastroenterology, Hepatology and Nutrition, The University of Texas Medical School at Houston, 77030 TX, United States.
Nirav ThosaniJennifer Shroff, Nirav Thosani, Sachin Batra, Sushovan Guha, Division of Gastroenterology, Hepatology and Nutrition, The University of Texas Medical School at Houston, 77030 TX, United States.
Sachin BatraJennifer Shroff, Nirav Thosani, Sachin Batra, Sushovan Guha, Division of Gastroenterology, Hepatology and Nutrition, The University of Texas Medical School at Houston, 77030 TX, United States.
Harminder SinghJennifer Shroff, Nirav Thosani, Sachin Batra, Sushovan Guha, Division of Gastroenterology, Hepatology and Nutrition, The University of Texas Medical School at Houston, 77030 TX, United States.
Sushovan GuhaJennifer Shroff, Nirav Thosani, Sachin Batra, Sushovan Guha, Division of Gastroenterology, Hepatology and Nutrition, The University of Texas Medical School at Houston, 77030 TX, United States.
The University of Texas Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo conduct a systematic review and meta-analysis of published population-based randomized controlled trials (RCTs).

methodsRCTs evaluating the difference in mortality and incidence of colorectal cancer (CRC) between a screening flexible sigmoidoscopy (FS) group and control group (not assigned to screening FS) with a minimum 5 years median follow-up were identified by a search of MEDLINE and EMBASE databases and the Cochrane Central Register for Controlled Trials through August 2013. Random effects model was used for meta-analysis.

resultsFour RCTs with a total of 165659 patients in the FS group and 249707 patients in the control group were included in meta-analysis. Intention-to-treat analysis showed that there was a 22% risk reduction in total incidence of CRC (RR = 0.78, 95%CI: 0.74-0.83), 31% in distal CRC incidence (RR = 0.69, 95%CI: 0.63-0.75), and 9% in proximal CRC incidence (RR = 0.91, 95%CI: 0.83-0.99). Those who underwent screening FS were 18% less likely to be diagnosed with advanced CRC (OR = 0.82, 95%CI: 0.71-0.94). There was a 28% risk reduction in overall CRC mortality (RR = 0.72, 95%CI: 0.65-0.80) and 43% in distal CRC mortality (RR = 0.57, 95%CI: 0.45-0.72).

conclusionThis meta-analysis suggests that screening FS can reduce the incidence of proximal and distal CRC and mortality from distal CRC along with reduction in diagnosis of advanced CRC.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerEquipment DesignHumansIncidenceOdds RatioPredictive Value of TestsRandomized Controlled Trials as TopicRisk FactorsSigmoidoscopesSigmoidoscopyColorectal CancerFlexible sigmoidoscopyIncidenceMeta-analysisMortalityRandomized control trials

Identifiers

PMID25561818
PMCPMC4277988
OpenAlexW2062754882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.